Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study.

Trial Profile

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2010

At a glance

  • Drugs Goserelin (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms PROOF
  • Sponsors AstraZeneca
  • Most Recent Events

    • 09 Dec 2010 Planned end date changed from Jan 2011 to Apr 2012 as reported by ClinicalTrials.gov.
    • 18 Aug 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 04 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top